000142080 001__ 142080
000142080 005__ 20240229105143.0
000142080 0247_ $$2doi$$a10.3389/fgene.2018.00558
000142080 0247_ $$2pmid$$apmid:30559759
000142080 0247_ $$2pmc$$apmc:PMC6286959
000142080 0247_ $$2altmetric$$aaltmetric:52117757
000142080 037__ $$aDKFZ-2018-02310
000142080 041__ $$aeng
000142080 082__ $$a570
000142080 1001_ $$aLimonciel, Alice$$b0
000142080 245__ $$aPersistence of Epigenomic Effects After Recovery From Repeated Treatment With Two Nephrocarcinogens.
000142080 260__ $$aLausanne$$bFrontiers Media$$c2018
000142080 3367_ $$2DRIVER$$aarticle
000142080 3367_ $$2DataCite$$aOutput Types/Journal article
000142080 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1549881185_1055
000142080 3367_ $$2BibTeX$$aARTICLE
000142080 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000142080 3367_ $$00$$2EndNote$$aJournal Article
000142080 520__ $$aThe discovery of the epigenetic regulation of transcription has provided a new source of mechanistic understanding to long lasting effects of chemicals. However, this information is still seldom exploited in a toxicological context and studies of chemical effect after washout remain rare. Here we studied the effects of two nephrocarcinogens on the human proximal tubule cell line RPTEC/TERT1 using high-content mRNA microarrays coupled with miRNA, histone acetylation (HA) and DNA methylation (DM) arrays and metabolomics during a 5-day repeat-dose exposure and 3 days after washout. The mycotoxin ochratoxin A (OTA) was chosen as a model compound for its known impact on HA and DM. The foremost effect observed was the modulation of thousands of mRNAs and histones by OTA during and after exposure. In comparison, the oxidant potassium bromate (KBrO3) had a milder impact on gene expression and epigenetics. However, there was no strong correlation between epigenetic modifications and mRNA changes with OTA while with KBrO3 the gene expression data correlated better with HA for both up- and down-regulated genes. Even when focusing on the genes with persistent epigenetic modifications after washout, only half were coupled to matching changes in gene expression induced by OTA, suggesting that while OTA causes a major effect on the two epigenetic mechanisms studied, these alone cannot explain its impact on gene expression. Mechanistic analysis confirmed the known activation of Nrf2 and p53 by KBrO3, while OTA inhibited most of the same genes, and genes involved in the unfolded protein response. A few miRNAs could be linked to these effects of OTA, albeit without clear contribution of epigenetics to the modulation of the pathways at large. Metabolomics revealed disturbances in amino acid balance, energy catabolism, nucleotide metabolism and polyamine metabolism with both chemicals. In conclusion, the large impact of OTA on transcription was confirmed at the mRNA level but also with two high-content epigenomic methodologies. Transcriptomic data confirmed the previously reported activation (by KBrO3) and inhibition (by OTA) of protective pathways. However, the integration of omic datasets suggested that HA and DM were not driving forces in the gene expression changes induced by either chemical.
000142080 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000142080 588__ $$aDataset connected to CrossRef, PubMed,
000142080 7001_ $$avan Breda, Simone G$$b1
000142080 7001_ $$0P:(DE-He78)079436c5442874052d541943e53145ef$$aJiang, Xiaoqi$$b2$$udkfz
000142080 7001_ $$aTredwell, Gregory D$$b3
000142080 7001_ $$aWilmes, Anja$$b4
000142080 7001_ $$aAschauer, Lydia$$b5
000142080 7001_ $$aSiskos, Alexandros P$$b6
000142080 7001_ $$aSachinidis, Agapios$$b7
000142080 7001_ $$aKeun, Hector C$$b8
000142080 7001_ $$0P:(DE-He78)bb6a7a70f976eb8df1769944bf913596$$aKopp-Schneider, Annette$$b9$$udkfz
000142080 7001_ $$ade Kok, Theo M$$b10
000142080 7001_ $$aKleinjans, Jos C S$$b11
000142080 7001_ $$aJennings, Paul$$b12
000142080 773__ $$0PERI:(DE-600)2606823-0$$a10.3389/fgene.2018.00558$$gVol. 9, p. 558$$p558$$tFrontiers in genetics$$v9$$x1664-8021$$y2018
000142080 909CO $$ooai:inrepo02.dkfz.de:142080$$pVDB
000142080 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)079436c5442874052d541943e53145ef$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000142080 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bb6a7a70f976eb8df1769944bf913596$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000142080 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000142080 9141_ $$y2018
000142080 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT GENET : 2017
000142080 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000142080 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000142080 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000142080 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000142080 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000142080 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000142080 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review
000142080 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000142080 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000142080 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000142080 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000142080 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000142080 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000142080 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lBiostatistik$$x0
000142080 980__ $$ajournal
000142080 980__ $$aVDB
000142080 980__ $$aI:(DE-He78)C060-20160331
000142080 980__ $$aUNRESTRICTED